Level of Knowledge of the Omicron Variant of the Sars-Cov2 Virus of Medical Students at Muhammadiyah Malang University
Abstract
The second wave of the COVID-19 pandemic in Indonesia has subsided. However, it has begun to spread in several countries with an increase in COVID-19 cases with a new variant, the Omicron variant (B.1.1.529), and its presence has been detected in Indonesia. This variant is suspected of having a greater transmission power than other virus variants. This condition affects education in Indonesia. Learning activities using blended methods began in the 2021-2022 academic year at the Medical Faculty at the University of Muhammadiyah Malang. It is necessary to know the level of knowledge of students about the Omicron variant as one of the basics for preventing and controlling this virus on campus. To determine the level of knowledge of students in the Academic Stage of the Faculty of Medicine, the University of Muhammadiyah Malang, on the characteristics of the Omicron variant SARS-CoV2 virus, this study uses a descriptive type of research with a cross-sectional study approach. The results of the study of 300 respondents showed that the average level of knowledge was 77.13%. This average is included in the good criteria. The level of knowledge of students at the academic stage of the Faculty of Medicine, University of Muhammadiyah Malang, on the characteristics of the Omicron variant SARS-CoV-2 virus is included in good criteria.
Keywords: knowledge level, SARS-Cov2, Omicron
References
[1] World Health Organization. Coronavirus (COVID-19) events as they happen. 2019.
[2] Idhom AM. Kronologi Pasien Positif Corona di Indonesia Bertambah Jadi Enam. Tirto.id. 2020.
[3] KEMENKES B. Peta Sebaran Sekuens dan Varian Covid-19 di Indonesia Badan Penelitian dan Pengembangan Kesehatan. 2021.
[4] CNN. Kasus Varian Omicron di Indonesia Bertambah Jadi 46 Kasus. 2021.
[5] WHO. Brief and Priority Actions for Member States. 2021;2021(November):1–8.
[6] Wang Z, Qiang W, Ke H. A Handbook of 2019-nCoV Pneumonia Control and Prevention. Hubei Sci Technol Press; 2020. pp. 1–108.
[7] Chen Y, Liu Q GD. Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology. 2020.
[8] Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020 Apr;181(2):281– 292.
[9] Brogan G, Campbell N, Durie M NC. Coronavirus disease 2019 (COVID-19) . LITFL. 2020.
[10] Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020 Mar;38(1):1–9.
[11] Chowdhury MA, Hossain N, Kashem MA et al. Immune Response in COVID-19_ A Review - ScienceDirect. 2020.
[12] CDC. What is Genomic Surveillance? https://www.cdc.gov/coronavirus/2019- ncov/variants/genomic-surveillance.html. 2021. pp. 1–2.
[13] CDC. Omicron Variant: What You Need to Know | CDC. Cdc. https://www.cdc.gov/coronavirus/2019-ncov/variants/index.html 2021.
[14] Wang L, Cheng G. Sequence analysis of the Emerging Sars-CoV-2 Variant Omicron in South Africa. J Med Virol. 2021.
[15] He X, Hong W, Lu G et al. SARS‐CoV‐2 Omicron variantnCharacteristics and prevention. MedComm. 2021.
[16] WHO. Update on Omicron. World Health Organization; 2021. pp. 1–5.
[17] RI Kemkes. Kasus Omicron Tambah Jadi 572 Orang, Kemenkes Perkuat Pelaksanaan 3T – Sehat Negeriku. 2022.